Show simple item record

dc.contributor.authorKarakecili, Faruk
dc.contributor.authorCikman, Aytekin
dc.contributor.authorAydin, Merve
dc.contributor.authorGulhan, Baris
dc.date.accessioned2020-08-07T13:24:08Z
dc.date.available2020-08-07T13:24:08Z
dc.date.issued2018-09
dc.identifier10.3343/alm.2018.38.5.446
dc.identifier.urihttp://hdl.handle.net/20.500.12498/3303
dc.description.abstractHigh asymmetrical dimethylarginine (ADMA) levels have been associated with endothelial dysfunction and contribute to the development of several diseases. However, data on the relationship between hepatitis B virus (HBV) and ADMA are limited. The aim of our study was to explore the relationship between ADMA and HBV by comparing the ADMA levels in patients with chronic active hepatitis B (CHB), inactive HBV carriers (carriers), and healthy volunteers (controls).
dc.language.isoeng
dc.sourceAnnals of laboratory medicine
dc.titleAsymmetrical Dimethylarginine Levels in Hepatitis B Virus-Positive Patients.
dc.typeArticle


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record